Xolair for food allergy in people with high IgE
Treatments studied
Part of Immune system & allergy clinical trials.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 55 years old.
- You have a clear allergy to at least one of these foods: peanut, cashew, walnut, egg, milk, or wheat.
- You have a history of reacting to a very small amount of that food during a doctor-supervised food challenge.
- You have high total IgE levels (a type of allergy antibody) that would have prevented you from joining a similar study.
- You do not have severe asthma, cancer, or a history of serious allergic reactions requiring breathing help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives a few doses of omalizumab (a medicine that blocks allergic reactions) and then does a food challenge to see if the patient can eat the food safely. It is for people who have already been prescribed this medicine for food allergy.
This study looks for blood test patterns that may predict whether a child with eczema (atopic dermatitis) is likely to have a food allergy. If you join, you may do supervised oral food challenges with a placebo and the suspected foods to see what triggers symptoms.
This trial studies whether starting omalizumab before asthma flare-ups begin can reduce how often children get worsening asthma that needs strong steroid medicine. It is for children with persistent asthma who have signs of allergic/asthma triggers and recent flare-up history.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
This study tests if omalizumab, an allergy medicine, can help people with COPD who are allergic to common indoor allergens and have had recent flare-ups. It aims to see if reducing allergic reactions can improve COPD control.
Hear when a new Food Hypersensitivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.